Jiangxi Rimag Group Co Ltd
HKEX:2522

Watchlist Manager
Jiangxi Rimag Group Co Ltd Logo
Jiangxi Rimag Group Co Ltd
HKEX:2522
Watchlist
Price: 5.64 HKD 0.71%
Market Cap: HK$2.3B

Wall Street
Price Targets

Price Targets Summary
Jiangxi Rimag Group Co Ltd

There are no price targets for Jiangxi Rimag Group Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Jiangxi Rimag Group Co Ltd Competitors:
Price Targets
BLFS
BioLife Solutions Inc
69% Upside
YUMC
Yum China Holdings Inc
29% Upside
TNDM
Tandem Diabetes Care Inc
70% Upside
URBN
Urban Outfitters Inc
30% Upside

Revenue
Forecast

-2% / Year
Past Growth
26% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-2% / Year
Past Growth
26% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 2 years the compound annual growth rate for Jiangxi Rimag Group Co Ltd's revenue is -2%. The projected CAGR for the next 3 years is 26%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Jiangxi Rimag Group Co Ltd's stock price target?
Not Available

Jiangxi Rimag Group Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Jiangxi Rimag Group Co Ltd's Revenue forecast?
Projected CAGR
26%

For the last 2 years the compound annual growth rate for Jiangxi Rimag Group Co Ltd's revenue is -2%. The projected CAGR for the next 3 years is 26%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett